Key terms
About OPRX
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Waltham, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OPRX news
Mar 25
8:50am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 12
9:02am ET
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)
Mar 11
4:42pm ET
OptimizeRx cuts FY24 revenue view to at least $100M from at least $110M
Mar 11
4:40pm ET
OptimizeRx backs FY23 revenue view at least $68M-$70M, consensus $69.85M
Mar 05
9:00am ET
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
Jan 27
4:17am ET
OptimizeRx Announces Board Changes in Press Release
Jan 27
4:16am ET
OptimizeRx Announces Leadership Changes and Board Expansion
Jan 25
8:50am ET
Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and OptimizeRx (OPRX)
Jan 25
7:36am ET
OptimizeRx announces Chairperson Halas retiring, Vos to succeed
Jan 10
9:10am ET
OptimizeRx price target raised to $17 from $14 at Lake Street
Jan 10
6:56am ET
RBC Capital Reaffirms Their Buy Rating on OptimizeRx (OPRX)
Jan 09
7:37am ET
OptimizeRx sees 2024 revenue at least $110M, consensus $110.29M
Jan 09
7:36am ET
OptimizeRx sees 2023 revenue exceeding $68M-$70M, consensus $$68.78M
Jan 02
5:09pm ET
OptimizeRx initiated with an Equal Weight at Barclays
No recent news articles are available for OPRX
No recent press releases are available for OPRX
OPRX Financials
Key terms
Ad Feedback
OPRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OPRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range